1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. 3D Printing in Medical Devices Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. High demand for personalized or customized medical devices
5.1.1.2. Awareness about 3D printing of medical devices provided by regulatory authorities
5.1.2. Restraints
5.1.2.1. High cost and quality concerns of 3D printed medical device
5.1.3. Opportunities
5.1.3.1. Advancements in printing materials and emergence of bioprinting
5.1.3.2. Enhanced potential in point-of-care diagnostics manufacturing
5.1.4. Challenges
5.1.4.1. Dearth of trained professionals for using 3D-printed medical device
5.2. Market Segmentation Analysis
5.2.1. Product Type: Increasing demand for prosthetics & implants for increased satisfaction with medical treatments
5.2.2. Technology: Rising adoption of photopolymerization technology for manufacturing microscale devices
5.2.3. Component: Growing utilization of various equipments based on material compatibility, and production speed
5.2.4. End User: Wider application across the hospitals for better patient care and efficiently streamline clinical workflows
5.3. Market Trend Analysis
5.3.1. Presence of native and established medical device market vendors offering innovative 3D printing technologies in the Americas
5.3.2. Government support to increase the manufacturing and usage of 3D medical devices in Asia-Pacific region
5.3.3. Advancements, Research and Development, and Investments in 3D Printing for Medical Devices in Europe and Middle East
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
6. 3D Printing in Medical Devices Market, by Product Type
6.1. Introduction
6.2. Bone & Cartilage Scaffolds
6.3. Ligament & Tendon Scaffolds
6.4. Prosthetics & Implants
6.5.1. Custom Implants
6.5.2. Standard Implants
6.5. Surgical Guides
6.6.1. Craniomaxillofacial Guides
6.6.2. Dental Guides
6.6.3. Orthopedic Guides
6.6. Surgical Instruments
6.7.1. Retractors
6.7.2. Scalpels
6.7.3. Surgical Fasteners
6.7. Tissue Engineering Products
7. 3D Printing in Medical Devices Market, by Technology
7.1. Introduction
7.2. Droplet Deposition/Extrusion-Based Technologies
7.3.1. Fused Deposition Modeling
7.3.2. Low-Temperature Deposition Manufacturing
7.3.3. Multiphase Jet Solidification
7.3. Electron Beam Melting
7.4. Laser Beam Melting
7.5.1. Direct Metal Laser Sintering
7.5.2. Selective Laser Melting
7.5.3. Selective Laser Sintering
7.5. Photopolymerization
7.6.1. Digital Light Processing
7.6.2. Polyjet 3D Printing Technology
7.6.3. Stereolithography
7.6.4. Two-Photon Polymerization
8. 3D Printing in Medical Devices Market, by Component
8.1. Introduction
8.2. Equipment
8.3. Materials
8.4.1. Ceramics
8.4.2. Paper
8.4.3. Resin
8.4. Services & Software
9. 3D Printing in Medical Devices Market, by End User
9.1. Introduction
9.2. Academic Institutions & Research Laboratories
9.3. Ambulatory Surgical Centers
9.4. Diagnostic Centers
9.5. Hospitals
10. Americas 3D Printing in Medical Devices Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific 3D Printing in Medical Devices Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa 3D Printing in Medical Devices Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
13.3.1. Merger & Acquisition
13.3.1.1. restor3d to acquire fellow 3D printed medical device firm Conformis
13.3.1.2. Zimmer Biomet to acquire medical device company OSSIS
13.3.1.3. Stratasys Completes Acquisition of Covestro’s Additive Manufacturing Materials Business
13.3.2. Agreement, Collaboration, & Partnership
13.3.2.1. EOS, Tecomet, Precision ADM, and OIC partner to provide end-to-end solution for medical device 3D printing
13.3.2.2. Materialise and Vuzix Announce Collaboration to Bring Smart Eyewear to Consumers
13.3.2.3. Stratasys Signs Agreement with Ricoh USA, Inc. for Print-On-Demand Medical Models
13.3.2.4. Desktop Metal and Henkel announce the onboarding of Loctite branded formulations on the Xtreme 8k machine
13.3.3. New Product Launch & Enhancement
13.3.3.1. Formlabs Introduces BioMed Durable Resin for Strong, Impact-Resistant Medical Devices
13.3.4. Investment & Funding
13.3.4.1. 9T Labs raises USD 17 million in Series A funding to advance carbon fiber 3D printing
13.3.5. Award, Recognition, & Expansion
13.3.5.1. Stryker Corporation opens new Additive Manufacturing facility in Ireland
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. 3D Systems Corporation
14.1.2. Abbott Laboratories
14.1.3. Anatomics Pty Ltd.
14.1.4. Anisoprint SARL
14.1.5. Ansys, Inc.
14.1.6. Apium Additive Technologies GmbH
14.1.7. Arkema SA
14.1.8. BICO Group
14.1.9. Biomedical Modeling Inc.
14.1.10. Carbon, Inc.
14.1.11. EOS GmbH
14.1.12. Evonik Industries AG
14.1.13. Formlabs Inc.
14.1.14. GE HealthCare Technologies Inc.
14.1.15. Henkel AG & Co. KGaA
14.1.16. Johnson & Johnson Services, Inc.
14.1.17. Materialise NV
14.1.18. Organovo Holdings Inc.
14.1.19. Prodways Group
14.1.20. Proto Labs, Inc.
14.1.21. RapidMade Inc.
14.1.22. Renishaw PLC
14.1.23. Restor3d, Inc.
14.1.24. Siemens AG
14.1.25. SLM Solutions Group AG
14.1.26. Smith & Nephew PLC
14.1.27. Solvay S.A.
14.1.28. Stratasys Ltd.
14.1.29. Stryker Corporation
14.1.30. Thermo Fisher Scientific Inc.
14.1.31. Zimmer Biomet Holdings, Inc.
14.1.32. Zortrax S.A.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing